At a Senate Health, Education, Labor, and Pensions Committee hearing, Sen. Rand Paul (R-Ky.) directly asked Moderna CEO Stéphane Bancel about the possibility of young men aged 16-24 developing myocarditis after receiving the COVID-19 vaccine.
Despite health officials downplaying the risk, the query was gaining attention in scientific studies. Paul pressed Bancel for an answer, and Bancel attempted to avoid the question.
Paul then repeated the query, to which Bancel replied that the data from the CDC has shown less myocarditis for those vaccinated than for those infected. When Paul followed up for further clarification, Bancel repeated the same answer.
Paul then declared his disagreement and entered into the congressional record six peer-reviewed studies showing the contrary.
He then revealed that he had recently spoken with the president of Moderna who, in private, acknowledged the myocarditis risk. Paul expressed his disapproval of Bancel’s denial of the risk in public.
In addition, Bancel admitted that his children had received multiple vaccine jabs and disclosed the $400 million Moderna payment to the National Institute of Allergy and Infectious Diseases.